文献速递临床试验与 GCP基础与转化研究

外源性酮体营养配方在Angelman综合征患者中的安全性与耐受性评估:FANS随机对照试验方案

Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial.
PubMed 文献 · Trials · 2020-01-09

本研究为16周随机双盲安慰剂对照交叉试验,评估含外源性β-羟基丁酸营养配方在Angelman综合征患者中的安全性与耐受性,并探索其对营养状况及生理、症状和健康结局的潜在影响。该研究首次提供外源性酮体用于Angelman综合征患者的数据。

要点

  • 生酮及低血糖指数饮食可有效治疗Angelman综合征儿童的耐药性癫痫。
  • 外源性酮体在Angelman综合征中促进酮症的作用此前未被研究。
  • FANS试验为16周随机双盲安慰剂对照交叉设计,评估安全性与耐受性。

核心结论

  • 该研究方案旨在首次提供外源性酮体营养方法用于Angelman综合征患者的数据。
  • 研究评估含外源性β-羟基丁酸配方的安全性与耐受性,并探索其对营养状况的潜在影响。

研究设计与样本

  • 16周随机、双盲、安慰剂对照、交叉研究,评估含外源性酮体的营养配方的安全性与耐受性。
  • 研究同时考察外源性酮体改善患者营养状况的潜力,营养状况可影响Angelman综合征的生理、症状和健康结局负担。
  • 试验注册于ClinicalTrials.gov,ID为NCT03644693,2018年8月23日注册,最后更新于2018年8月23日。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Ketogenic and low-glycemic-index diets are effective in treating drug-resistant seizures in children with Angelman syndrome. Cognition, mobility, sleep, and gastrointestinal health are intrinsically linked to seizure activity and overall quality of life. Ketogenic and low-glycemic diets restrict carbohydrate consumption and stabilize blood glucose levels. The ketogenic diet induces ketosis, a metabolic state where ketone bodies are preferentially used for fuel. The use of exogenous ketones in promoting ketosis in Angelman syndrome has not been previously studied. The study formulation evaluated herein contains the exogenous ketone beta-hydroxybutyrate to rapidly shift the body towards ketosis, resulting in enhanced metabolic efficiency. METHODS/DESIGN: This is a 16-week, randomized, double-blind, placebo-controlled, crossover study to assess the safety and tolerability of a nutritional formula containing exogenous ketones. It also examines the potential for exogenous ketones to improve the patient's nutritional status which can impact the physiologic, symptomatic, and health outcome liabilities of living with Angelman syndrome. DISCUSSION: This manuscript outlines the rationale for a study designed to be the first to provide data on nutritional approaches for patients with Angelman syndrome using exogenous ketones. TRIAL REGISTRATION: ClinicalTrials.gov, ID: NCT03644693. Registered on 23 August 2018. Last updated on 23 August 2018.

来源:Trials,查看原文。版权归原作者所有。

引用

  1. Herber DL, Weeber EJ, D'Agostino DP, et al. Evaluation of the safety and tolerability of a nutritional Formulation in patients with ANgelman Syndrome (FANS): study protocol for a randomized controlled trial. Trials. 2020. PMID: 31918761. doi:10.1186/s13063-019-3996-x

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。